[Treatment of intracapillary-proliferative glomerulonephritis].
It is reported on 137 patients with chronic intracapillary-proliferative glomerulonephritides. Of them 101 patients were treated with prednisolone, 36 patients remained untreated. The control biopsies and the observations of the course after on an average 1.8 years showed that the treated patients clinically and histologically had no better results than the untreated patients. A relatively high number of urinary tract infections and pyelonephritides was evident in patients treated with prednisolone. These diseases did not occur in patients who were not treated.
D002908:Chronic Disease; D004912:Erythrocytes; D005921:Glomerulonephritis / Q000628:therapy*; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007668:Kidney / Q000473:pathology*; D010406:Penicillins / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D014556:Urine / Q000166:cytology
D010406:Penicillins; D011239:Prednisolone
Zur Behandlung der intrakapillär-proliferativen Glomerulonephritis.